CAIN CHRISTOPHER W. — SEC Form 4 filings
SEC reporting owner CIK 1817733. 9 Form 4 filings on record with FilingPulse; latest filed 2026-07-02.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2024-06-13 to 2026-07-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 9.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Cogent Biosciences, Inc. (COGT) | Director | 3 | — | — | 3 |
| Viridian Therapeutics, Inc.\DE (VRDN) | Director | 3 | — | — | 3 |
| Jade Biosciences, Inc. (JBIO) | Director | 2 | — | — | 2 |
| Damora Therapeutics, Inc. (DMRA) | Director | 1 | — | — | 1 |
Form 4 filings — CAIN CHRISTOPHER W.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-02 | 4 | Viridian Therapeutics, Inc.\DE (VRDN) | Grant/award (A): 32,341 (derivative) @ $0 | EDGAR |
| 2026-06-11 | 4 | Cogent Biosciences, Inc. (COGT) | Grant/award (A): 17,901 (derivative) @ $0 | EDGAR |
| 2026-06-11 | 4 | Jade Biosciences, Inc. (JBIO) | Grant/award (A): 34,843 (derivative) @ $0 | EDGAR |
| 2026-03-25 | 4 | Damora Therapeutics, Inc. (DMRA) | Grant/award (A): 37,313 (derivative) @ $0 | EDGAR |
| 2025-07-02 | 4 | Viridian Therapeutics, Inc.\DE (VRDN) | Grant/award (A): 21,000 (derivative) @ $0 | EDGAR |
| 2025-06-05 | 4 | Cogent Biosciences, Inc. (COGT) | Grant/award (A): 44,700 (derivative) @ $0 | EDGAR |
| 2025-05-01 | 4 | Jade Biosciences, Inc. (JBIO) | Grant/award (A): 23,017 (derivative) @ $0 | EDGAR |
| 2025-03-12 | 4 | Viridian Therapeutics, Inc.\DE (VRDN) | Grant/award (A): 42,000 (derivative) @ $0 | EDGAR |
| 2024-06-13 | 4 | Cogent Biosciences, Inc. (COGT) | Grant/award (A): 44,700 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1817733 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →